Methylsulphate

Active pharmaceutical substance formulated in Jan Aushadhi generic products for CNS, Nerve & Mental Health treatment.

🧴 Clinical Application

Administered by anesthesiologists or intensive care physicians by slow intravenous injection, always preceded or accompanied by an anticholinergic agent (atropine or glycopyrrolate) to prevent severe muscarinic bradycardia and bronchospasm. Continuous monitoring of heart rate and respiration is mandatory.

⚠️ Side Effects

Common: Excessive salivation, nausea, diarrhea, abdominal cramps, sweating, muscle fasciculations. Rare/Severe: Severe bradycardia, heart block, cardiac arrest, cholinergic crisis, and severe bronchospasm.

🛡️ Safety Warnings

Must always be co-administered with atropine or glycopyrrolate to counteract potentially fatal muscarinic bradycardia and asystole. Contraindicated in mechanical intestinal or urinary obstruction and peritonitis. Resuscitation equipment must be present.